Navigation Links
AyoxxA Biosystems Closes Series A Financing Round
Date:9/20/2012

Christine; Board Members Regina Hodits, Matthias Dill and Aristotelis Nastos (NRW.BANK); and Board Observers Lukas Günther (Wellington Partners) and Florian Stinauer (NRW.BANK).

About AyoxxA

AyoxxA, an international biotech company based in Cologne, Germany, and Singapore, has developed a proprietary technology platform for multiplexed protein analysis. Core to this cutting-edge technology are "In-situ Encoded Bead-based Arrays" (IEBA) which allow simultaneous, precise and cost effective protein analysis in very small sample volumes.

These novel biochips allow users to combine high throughput screening and multiplexed assay formats at the same time and thus have the potential to revolutionize applications in biomedical research, pharmacological screening, and diagnostics.

AyoxxA was founded as a spin-off of the National University of Singapore (NUS) in 2010. The company received multiple grants in Singapore from the National Research Foundation (NRF), the SMART Innovation Centre (Singapore MIT Alliance for Research and Technology), and SPRING's Technology Enterprise Commercialisation Scheme (TECS). It established corporate headquarters in Cologne in Spring 2012 and continues to run operations in Singapore.

Contacts

Dr. Andreas Schmidt, CEO
AyoxxA Biosystems GmbH
BioCampus Cologne
Nattermannallee 1
50829 Köln, Germany
Phone:+49(0)221-222529-0
E-Mail: info@ayoxxa.com
http://www.ayoxxa.com

AyoxxA Living Health Technologies Pte. Ltd National University of Singapore (NUS)
Block E3A, #07-02, 7 Engineering Drive 1
117576 Singapore
Phone: +65-65166482

Citigate Dewe Rogerson
Chris Gardner/Nina Enegren
Tel: +44(0)20-7638-9571
nina.enegren@citigatedr.co.uk


'/>"/>
SOURCE AyoxxA
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Aushon BioSystems Appoints Martin Verhoef Chief Executive Officer
2. Ahram Biosystems Announces Launch of the New Economy Model F1-12 of Its Palm PCR Series
3. OncoSec Closes $7.75 Million Public Offering
4. Avaxia Biologics, Inc. Closes $4.1 Million Series A Financing to Advance Oral Antibodies for Inflammatory Bowel Disease
5. Radius Closes $27.65 Million Second Tranche of Previously Announced Financing
6. Relmada Therapeutics Raises $3.0 Million In Initial Closing Of Series A Financing
7. Juventas Therapeutics Raises $22.2 Million Series B Financing
8. Vision Research Introduces the Newest Member Of the Phantom®- 1Mpx- v-Series Camera Family
9. Rhythm Raises $25M in Series B Financing for Diabetes and Obesity Therapeutics
10. Sangart Raises Additional $50M Series G Funding Following Interim Safety Analysis Of Phase 2b Study Of MP4OX In Severe Trauma Patients With Hemorrhagic Shock
11. 23andMe Provides the Science Behind PBS Series "Finding Your Roots with Henry Louis Gates, Jr." With Its Personal Genome ServiceĀ®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/13/2014)... December 12, 2014 Trend lines for ... overall global economic growth, Eugene Arthurs, CEO of ... said in a featured talk at OPTIC (Optics and ... the National Chung Hsing University in Taichung. , As ... into future energy supplies and soon to hit US$50 ...
(Date:12/13/2014)... 13, 2014 According to population studies: ... between now and 2030." If a population explosion like ... most populous state in the country. , To that ... the Future of North Carolina Forum on December 16th ... have the necessary infrastructure in place? Enough clean water? ...
(Date:12/13/2014)... -- Vermillion, Inc. (NasdaqCM: VRML), a bio-analytical solutions company focused on ... G. H. Jordan , Ph.D., and David R. ... the total number of directors to eight, seven of ... , Chairman, President, and Chief Executive Officer of Vermillion, ... of Veronica and David to our board of directors.  ...
(Date:12/13/2014)... , Dec. 12, 2014  Vaccinex Inc., ... discovery and development of therapeutic monoclonal antibodies ... announced publication of a manuscript entitled "SEMA4D ... remyelination in neurodegenerative disease" in the January ... Disease*.  The publication highlights an important role ...
Breaking Biology Technology:Photonics Continues Upward Trends Despite Challenges in the Global Economy, Notes SPIE CEO 2Photonics Continues Upward Trends Despite Challenges in the Global Economy, Notes SPIE CEO 3Photonics Continues Upward Trends Despite Challenges in the Global Economy, Notes SPIE CEO 4Photonics Continues Upward Trends Despite Challenges in the Global Economy, Notes SPIE CEO 5North Carolina Chamber of Commerce: Asking Questions & Gathering Answers with a Futurist 2Vermillion Strengthens Board of Directors with Appointments of Veronica Jordan, Ph.D., and David Schreiber 2Vermillion Strengthens Board of Directors with Appointments of Veronica Jordan, Ph.D., and David Schreiber 3Vaccinex announces publication of preclinical studies with an anti-SEMA4D antibody in animal models of neuroinflammatory and demyelinating disease 2
... U.S. Food and Drug Administration clears new implant for ... Innovations, Inc. (SBi),a single-source provider of products, technology and ... orthopedic industry, announced that its,Artelon(R) STT Spacer has been ... This product extends SBi,s line of surgically implanted, ...
... FRAZER, Pa., Sept. 21 Cephalon, Inc. (Nasdaq:,CEPH) ... Drug Application (NDA) to,the U.S. Food and Drug ... the treatment of patients with chronic,lymphocytic leukemia (CLL). ... disease with an estimated 15,000 new cases diagnosed ...
... CLARA, California, September 21, ChemAxon, a software solutions ... A ) today announced an,agreement to maintain the ... ChemAxon,s software suite. Agilent acquired,the Kalabie ELN from ... between Klee and ChemAxon to Agilent and ChemAxon. ...
Cached Biology Technology:Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis 2Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis 3Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis 4Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis 5Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia 2Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia 3Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia 4ChemAxon and Agilent Technologies Sign Agreement Extending JChem Integration With Kalabie Electronic Lab Notebook 2
(Date:11/21/2014)... , Nov. 19, 2014  Earlier this year ... York College, and one of the most prolific inventors ... that are transmitted from Smartphones to third party agencies. ... and has one of the earliest known patents in ... usage in the military, child care, elder care and ...
(Date:11/18/2014)... Nov. 18, 2014  The Secure Identity & ... today jointly announce the formation of The Airport ... its Identity and Biometric Entry and Exit ... received official support from BORDERPOL, the international non-profit ... and provide expertise regarding border security, traveler and ...
(Date:11/15/2014)... YORK , Nov. 13, 2014  While we may ... technology Doctor McCoy used in "Star Trek" to gain instant ... tools designed to work with smartphones and tablets for monitoring ... of the healthcare world. This may seem a tad Orwellian ... ready to adopt some of these technological opportunities into their ...
Breaking Biology News(10 mins):Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 3Americans May Be Ready for a Brave New World of Healthcare 2Americans May Be Ready for a Brave New World of Healthcare 3Americans May Be Ready for a Brave New World of Healthcare 4
... Plan enacted in 1993 was designed to conserve old-growth forests ... researchers conclude in a new study that it had another ... lands. When forest harvest levels fell 82 percent on ... act, they became a significant carbon "sink" for the first ...
... do the infectious protein particles called prions come from? ... such as mad cow/Creutzfeld-Jakob disease, in humans and animals. ... folded protein counterparts, but they usually need some kind ... University School of Medicine have identified a yeast protein ...
... the Gulf of Mexico following the Deepwater Horizon oil spill, ... at Texas Tech University have reported that only 8 to ... eggs resulted in a 50 percent mortality rate. However, ... at sea and exposed to weather had a significant effect ...
Cached Biology News:Northwest Forest Plan has unintended benefit - carbon sequestration 2Cellular stress can induce yeast to promote prion formation 2Deepwater Horizon crude less toxic to bird eggs after weathering at sea 2
... serum is extensively scrutinized, including ... All horses are of ... worming are controlled and documented ... consistency. Pricing: $12/unit ...
... new primer sets added in Dec 2005 ... hours , Detection from as little ... Specific primers available for hundreds of mammalian ... or end-point RT-PCR , Ideal for ...
jub, ajuba homolog (Xenopus laevis)...
Recommend to use at up to 5000X dilutions for cell culture (e.g. Add 1 ul to 1 ml of culture medium.)...
Biology Products: